Bookman Michael

CHIEF LEGAL OFFICER, SECRETARYImmuneering Corp (IMRX) · full profile →Form 4 · filed May 23, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
0 non-derivative · 8 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 21, 2024Disposed to issuer(D)101K$00
May 21, 2024Grant(A)101K$0101K
May 21, 2024Disposed to issuer(D)47K$00
May 21, 2024Grant(A)47K$047K
May 21, 2024Disposed to issuer(D)143K$00
May 21, 2024Grant(A)143K$0143K
May 21, 2024Disposed to issuer(D)93K$00
May 21, 2024Grant(A)93K$093K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-24-024953) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about IMRX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001628280-24-024953"
Ask your agent
Use Arkolith to summarize insider buying and selling at Immuneering Corp
over the last 90 days and cite the filings.